Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 64 (6), 365-70

Second Meeting of the French CEIP (Centres d'Evaluation Et d'Information Sur La Pharmacodépendance). Part II: Benzodiazepine Withdrawal

Affiliations

Second Meeting of the French CEIP (Centres d'Evaluation Et d'Information Sur La Pharmacodépendance). Part II: Benzodiazepine Withdrawal

Nicolas Authier et al. Therapie.

Abstract

The aim of this meeting was to describe the news trends about abuse and addiction of anxiolytics and hypnotics. The part II of this meeting reviewed several aspects of the withdrawing benzodiazepines focusing in particular on clinical symptoms, biological patterns, and strategies for discontinuation. The discontinuation is usually beneficial due to the importance of adverse effects induced by long-term use of benzodiazepines. Several clinicals options have been described including gradual tapering of the current benzodiazepine, substitution with a long acting benzodiazepines or treating the symptoms of withdrawal. Psychological interventions range from a simple support through counselling to expert cognitive-behavioural therapy. However more controlled clinical trials are needed to promote adequate and optimal patient care in management of benzodiazepine withdrawing.

Similar articles

See all similar articles

Publication types

MeSH terms

LinkOut - more resources

Feedback